ALC-0159

ALC-0159, a polyethylene glycol (PEG) lipid conjugate, could be used as vaccine excipient[1].

1849616-42-7

12352211

H302, H315, H319, H335

Liposome

Oligonucleotides

Metabolic Enzyme/Protease

COVID-19-immunoregulation

Inflammation/Immunology

https://www.medchemexpress.com/alc-0159.html

99.93

DMSO : 100 mg/mL (ultrasonic) |Ethanol : ≥ 50 mg/mL

CCCCCCCCCCCCCCN(C(COCCOC)=O)CCCCCCCCCCCCCC.[n]

(C2H4O) nC31H63NO2

H302, H315, H319, H335

[1]S Moein Moghimi, et al. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Mol Ther. 2021 Mar 3;29 (3) :898-900.

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

http://file.medchemexpress.com/batch_PDF/HY-138300/ALC-0159-SDS-MedChemExpress.pdf

Oligonucleotides

No Development Reported